The Poly(A)-Binding Protein Nuclear 1 Suppresses Alternative Cleavage and Polyadenylation Sites

[1]  Reuven Agami,et al.  3′UTR-Mediated Gene Silencing of the Mixed Lineage Leukemia (MLL) Gene , 2011, PloS one.

[2]  K. Nishida,et al.  Mechanisms and consequences of alternative polyadenylation. , 2011, Molecules and Cells.

[3]  R. Agami,et al.  MicroRNA regulation by RNA-binding proteins and its implications for cancer , 2011, Nature Reviews Cancer.

[4]  Chong-Jian Chen,et al.  Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing. , 2011, Genome research.

[5]  Peter J. Shepard,et al.  Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq. , 2011, RNA.

[6]  D. Rubinsztein,et al.  Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophy , 2011, Human molecular genetics.

[7]  D. Bartel,et al.  Formation, Regulation and Evolution of Caenorhabditis elegans 3′UTRs , 2010, Nature.

[8]  P. Kapranov,et al.  Comprehensive Polyadenylation Site Maps in Yeast and Human Reveal Pervasive Alternative Polyadenylation , 2010, Cell.

[9]  A. Virtanen,et al.  To polyadenylate or to deadenylate , 2010, Cell cycle.

[10]  R. Elkon,et al.  A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility , 2010, Nature Cell Biology.

[11]  W. Filipowicz,et al.  Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.

[12]  J. Lemay,et al.  Crossing the borders: Poly(A)-binding proteins working on both sides of the fence , 2010, RNA biology.

[13]  Bin Tian,et al.  A functional human Poly(A) site requires only a potent DSE and an A-rich upstream sequence , 2010, The EMBO journal.

[14]  Andrew H. Beck,et al.  3′-End Sequencing for Expression Quantification (3SEQ) from Archival Tumor Samples , 2010, PloS one.

[15]  David Haussler,et al.  The UCSC Genome Browser database: update 2010 , 2009, Nucleic Acids Res..

[16]  Peter M Woollard Asking complex questions of the genome without programming. , 2010, Methods in molecular biology.

[17]  M. Schatz,et al.  Searching for SNPs with cloud computing , 2009, Genome Biology.

[18]  A. Riccio,et al.  To localize or not to localize: mRNA fate is in 3'UTR ends. , 2009, Trends in cell biology.

[19]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[20]  E. Wahle,et al.  Poly(A) Tail Length Is Controlled by the Nuclear Poly(A)-binding Protein Regulating the Interaction between Poly(A) Polymerase and the Cleavage and Polyadenylation Specificity Factor* , 2009, The Journal of Biological Chemistry.

[21]  B. Tian,et al.  Progressive lengthening of 3′ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development , 2009, Proceedings of the National Academy of Sciences.

[22]  J. Yates,et al.  Molecular architecture of the human pre-mRNA 3' processing complex. , 2009, Molecular cell.

[23]  C. Lutz,et al.  Alternative polyadenylation: a twist on mRNA 3' end formation. , 2008, ACS chemical biology.

[24]  R. Shamir,et al.  Transcription factor and microRNA motif discovery: the Amadeus platform and a compendium of metazoan target sets. , 2008, Genome research.

[25]  P. Sharp,et al.  Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites , 2008, Science.

[26]  R. Agami,et al.  Interplay between microRNAs and RNA-binding proteins determines developmental processes , 2008, Cell cycle.

[27]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[28]  Reuven Agami,et al.  RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA , 2007, Cell.

[29]  Reuven Agami,et al.  Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation , 2007 .

[30]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[31]  Bin Tian,et al.  PolyA_DB 2: mRNA polyadenylation sites in vertebrate genes , 2007, Nucleic Acids Res..

[32]  Reuven Agami,et al.  Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. , 2007, The EMBO journal.

[33]  Mariette Schrier,et al.  A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors , 2006, Cell.

[34]  L. Kappos,et al.  Oculopharyngeal muscular dystrophy - an under-diagnosed disorder? , 2005, Swiss medical weekly.

[35]  B. Tian,et al.  Bioinformatic identification of candidate cis-regulatory elements involved in human mRNA polyadenylation. , 2005, RNA.

[36]  D. Rubinsztein,et al.  Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice , 2005, Nature Medicine.

[37]  D. Bentley,et al.  Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. , 2005, Current opinion in cell biology.

[38]  M. Carmo-Fonseca,et al.  In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1. , 2005, RNA.

[39]  Bin Tian,et al.  A large-scale analysis of mRNA polyadenylation of human and mouse genes , 2005, Nucleic acids research.

[40]  S. Masich,et al.  Nuclear poly(A)-binding protein PABPN1 is associated with RNA polymerase II during transcription and accompanies the released transcript to the nuclear pore. , 2003, Experimental cell research.

[41]  D. Rubinsztein,et al.  Mammalian, Yeast, Bacterial, and Chemical Chaperones Reduce Aggregate Formation and Death in a Cell Model of Oculopharyngeal Muscular Dystrophy* , 2002, The Journal of Biological Chemistry.

[42]  D. Gautheret,et al.  Patterns of variant polyadenylation signal usage in human genes. , 2000, Genome research.

[43]  U. Kutay,et al.  Deciphering the cellular pathway for transport of poly(A)-binding protein II. , 2000, RNA.

[44]  J. Manley,et al.  Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation. , 1998, Molecular cell.

[45]  J. Rommens,et al.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy , 1998, Nature Genetics.

[46]  S. Blumen,et al.  Epidemiology and inheritance of oculopharyngeal muscular dystrophy in Israel , 1997, Neuromuscular Disorders.

[47]  F. Thomé,et al.  CAPD in southern Brazil: an epidemiological study. , 1997, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[48]  J. Manley,et al.  The Polyadenylation Factor CstF-64 Regulates Alternative Processing of IgM Heavy Chain Pre-mRNA during B Cell Differentiation , 1996, Cell.

[49]  E. Wahle,et al.  Poly(A) Tail Length Control Is Caused by Termination of Processive Synthesis (*) , 1995, The Journal of Biological Chemistry.

[50]  B. Hames,et al.  RNA processing : a practical approach , 1994 .

[51]  J. Bonner,et al.  Differentiation , 1968, Nature.